首页> Journal for immunotherapy of cancer> Changes in T-cell subsets and clonal repertoire during chemoimmunotherapy with pembrolizumab and paclitaxel or capecitabine for metastatic triple-negative breast cancer.

Changes in T-cell subsets and clonal repertoire during chemoimmunotherapy with pembrolizumab and paclitaxel or capecitabine for metastatic triple-negative breast cancer.

导出 LinkOut

翻译打印收藏纠错

第一作者： Brie,Chun

第一单位： Earle A Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA.

作者： Brie,Chun ^[1] ; Joanna,Pucilowska ^[2] ; ShuChing,Chang ^[3] ; Isaac,Kim ^[1] ; Benjamin,Nikitin ^[1] ; Yoshinobu,Koguchi ^[1] ; William L,Redmond ^[1] ; Brady,Bernard ^[4] ; Venkatesh,Rajamanickam ^[4] ; Nathan,Polaske ^[5] ; Paul A,Fields ^[5] ; Valerie,Conrad ^[1] ; Mark,Schmidt ^[1] ; Walter J,Urba ^[1] ; Alison K,Conlin ^[1] ; Heather L,McArthur ^[6] ; David B,Page ^[7]

作者单位： Earle A Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA. ^[1] Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA. ^[2] Medical Data Research Center, Providence St Joseph Health, Portland, Oregon, USA. ^[3] Earle A Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA.;Computational Immuno-Oncology and Bioinformatics Core, Earle A. Chiles Research Institute, Portland, Oregon, USA. ^[4] Adaptive Biotechnologies Corp, Seattle, Washington, USA. ^[5] Department of Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA. ^[6] Earle A Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA david.page2@providence.org. ^[7]

关键词 T-lymphocytes biostatistics breast neoplasms immunotherapy lymphocytes tumor-infiltrating